DHEAUSA.COM


Français


English


Русский


Español


Português


Deutsch


Italiano


Swedish


Dutch


日本語
 
 
Merchant Services

     
 

Home

 
 

Contact

 
 

Terms & Conditions

 
 

- - -  Products  - - -

 
 

DHEA

 
 

Melatonin

 
 

Symbiotropin

 
 

Meditropin

 
 

Testron SX

 
 

ProDHEA Cream

 
 

Melatonine Cream

 
 

ProGen Cream

 
 

Glucosamine

 
 

-  Information  -

 
 

Benefits of DHEA

 
 

Products Quality

 
 

DHEA History

 
 

Melatonin Update

 
 

Customers Comments

 
 

Medical Testimonials

 
     

 

Osteoporosis

 

Osteoporosis (bone thinning) affects millions of late-middle-aged to elderly individuals of both sexes, but is more common in women than men. In women, a major contributing factor is the loss of estrogen at menopause, which parallels the decline in DHEA. DHEA appears to exert a positive role in bone metabolism by inhibiting bone resorption and stimulating bone formation.
It also seems to aid calcium absorption. DHEA has proved effective in clinical trials treating osteoporosis.
However, a correlation between DHEA and bone mineral density appears variably in women and not at all in men.

 

Clinical Studies

  • Department of Gerontology, Shanghai Sixth People's Hospital, Shanghai 200233, China.
    To study the effect of dehydroepiandrosterone sulfate (DHEAS) treatment of osteoporosis in men with T(BMD) > or = 2.5SD. Eighty-six patients were randomly divided into two groups: treatment group (n = 44) and control group (n = 42). DHEAS (100 mg q.d.) was given to the treatment group for 6 months. Bone mineral density, (BMD), biochemical markers of bone absorption and formation and other serum biochemical markers were measured before and after DHEAS treatment. Drug side effects were also evaluated. After oral administration of DHEAS (100 mg q.d.) for 6 months, the serum concentrations of DHEAS and IGF-I in the treatment group were 93.75% +/- 16.1% and 17.71% +/- 4.2% higher respectively than those in the control group (P < 0.01). The BMD of L2, L3, L4, L2 - 4 and Neck sections increased in the treatment group by 2.65% +/- 0.65%, 2.70% +/- 0.48%, 3.10% +/- 0.41%, 2.82% +/- 0.37% and 2.32% +/- 0.31%, respectively, as compared with that the control group (P < 0.05 or 0.01). No significant changes were observed in serum FT, E(2) and PSA concentrations in the treatment group as compared with the control group. The treatment of osteoporosis in men with DHEAS is safe and effective.

 

 

 

 

 

 

 

 

 

 

 




  Copyright 2001- 2017 © DHEAUSA.COM   All rights reserved.